Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07CQJ
|
||||
| Former ID |
DIB000212
|
||||
| Drug Name |
F-50040
|
||||
| Synonyms |
Metastatic melanoma vaccine, Pierre Fabre; P40-ELA; Metastatic melanoma vaccine, BioMerieux-Pierre Fabre; Vaccine (melanoma), Pierre Fabre; Vaccine (melanoma), BioMerieux-Pierre Fabre
|
||||
| Indication | Melanoma [ICD9: 172; ICD10:C43] | Discontinued in Phase 1 | [547414] | ||
| Company |
Pierre Fabre SA
|
||||
| Target and Pathway | |||||
| Target(s) | MART-1 melanoma antigen | Target Info | Modulator | [526271] | |
| Toll-like receptor 2 | Target Info | Modulator | [526271] | ||
| KEGG Pathway | Phagosome | ||||
| PI3K-Akt signaling pathway | |||||
| Toll-like receptor signaling pathway | |||||
| Legionellosis | |||||
| Leishmaniasis | |||||
| Chagas disease (American trypanosomiasis) | |||||
| Malaria | |||||
| Toxoplasmosis | |||||
| Amoebiasis | |||||
| Tuberculosis | |||||
| Hepatitis B | |||||
| Measles | |||||
| Herpes simplex infection | |||||
| Proteoglycans in cancer | |||||
| Inflammatory bowel disease (IBD) | |||||
| Rheumatoid arthritis | |||||
| NetPath Pathway | IL4 Signaling Pathway | ||||
| TCR Signaling Pathway | |||||
| PANTHER Pathway | Toll receptor signaling pathway | ||||
| Pathway Interaction Database | Endogenous TLR signaling | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.